1 Executive Summary
2 Market Introduction
2.1 Definition 16
2.2 Scope of the Study 16
2.3 Market Structure 16
3 Research Methodology
3.1 Research Process 17
3.2 Primary Research 18
3.3 Secondary Research 18
3.4 Market Size Estimation 19
3.5 Forecast Model 20
4 Market Dynamics
4.1 Overview 21
4.2 Drivers 22
4.2.1 Growth in Outsourcing of Non-Core Functions 22
4.2.2 Enhanced Abilities of Preclinical CROs to Offer Additional Value-Added Services 22
4.2.3 Surging Number of Drugs in the Preclinical Phase 22
4.2.4 Economies of Production and Scale 22
4.2.5 Mutual Benefit to the Contractor as Well as the Client 22
4.2.6 High R&D Expenditure 23
4.3 Restraints 24
4.3.1 Scarcity of Labour and High Labour Cost 24
4.3.2 Structural Changes in the Industry 24
4.4 Opportunity 24
4.4.1 Opportunity for Medical Device Companies to Outsource Preclinical Trials to CROs 24
4.5 Challenges 25
4.5.1 Supply Chain Complexity and Third-Party Control 25
4.5.2 Outdated Clinical Trial Activities 25
4.6 Macroeconomic Indicators 25
4.7 Trends 25
5 Market Factor Analysis
5.1 Value Chain Analysis 26
5.1.1 R&D 26
5.1.2 Good Laboratory Practices (GLP) 26
5.1.3 Pre-Clinical CRO Testing 26
5.2 Porter’s Five Forces Analysis 27
5.2.1 Bargaining Power of Suppliers 27
5.2.2 Bargaining Power of Buyers 27
5.2.3 Threat of New Entrants 28
5.2.4 Threat of Substitutes 28
5.2.5 Intensity of Rivalry 28
5.3 Investment Opportunities 28
5.4 Pricing Analysis 28
6 Preclinical CRO Market, By Service
6.1 Overview 29
6.2 Toxicology Testing 31
6.3 Bioanalysis and Drug Metabolism and Pharmacokinetics (DMPK) Studies 32
6.4 Others 33
7 Preclinical CRO Market, By Therapeutic Area
7.1 Overview 34
7.2 Oncology 36
7.3 Central Nervous System (CNS) Disorders 37
7.4 Cardiovascular Diseases 38
7.5 Immunological Disorders 39
7.6 Respiratory Diseases 40
7.7 Infectious Diseases 41
7.8 Diabetes 42
7.9 Others 43
8 Preclinical CRO Market, By End User
8.1 Overview 44
8.2 Pharmaceutical and Biopharmaceutical Industries 46
8.3 Medical Device Companies 47
8.4 Academic Institutes 48
9 Global Preclinical CRO Market, By Region
9.1 Overview 49
9.2 Americas 51
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.2.1 North America 53
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.2.1.1 US 56
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.2.1.2 Canada 57
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.2.2 Latin America 59
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.3 Europe 61
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.3.1 Western Europe 63
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.3.1.1 Germany 66
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.3.1.2 France 67
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.3.1.3 UK 69
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.3.1.4 Italy 70
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.3.1.5 Spain 72
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.3.1.6 Rest of Western Europe 73
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.3.2 Eastern Europe 75
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.4 Asia-Pacific 77
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.4.1 Japan 80
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.4.2 China 81
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.4.3 India 83
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.4.4 Australia 84
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.4.5 South Korea 86
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.4.6 Rest of Asia-Pacific 87
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.5 Middle East & Africa 89
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.5.1 Middle East 91
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
9.5.2 Africa 93
Preclinical CRO Market, By Service
Preclinical CRO Market, By Therapeutic Area
Preclinical CRO Market, By End User
10 Competitive Landscape
10.1 Introduction 95
10.2 Company Share Analysis 95
11 Company Profile
11.1 IQVIA 99
11.1.1 Company Overview 99
11.1.2 Financial Overview 99
11.1.3 Products/Services Offered 100
11.1.4 Key Developments 100
11.1.5 SWOT Analysis 101
11.1.6 Key Strategies 101
11.2 PAREXEL International Corporation 102
11.2.1 Company Overview 102
11.2.2 Financial Overview 102
11.2.3 Products Offering 103
11.2.4 Key Developments 103
11.2.5 SWOT Analysis 103
11.2.6 Key Strategies 103
11.3 Envigo 104
11.3.1 Company Overview 104
11.3.2 Financial Overview 104
11.3.3 Products Offering 104
11.3.4 Key Developments 104
11.3.5 SWOT Analysis 105
11.3.6 Key Strategies 105
11.4 Charles River 106
11.4.1 Company Overview 106
11.4.2 Financial Overview 106
11.4.3 Products/Services Offered 106
11.4.4 Key Developments 107
11.4.5 SWOT Analysis 107
11.4.6 Key Strategies 107
11.5 Eurofins Scientific 108
11.5.1 Company Overview 108
11.5.2 Financial Overview 108
11.5.3 Products/Services Offered 108
11.5.4 Key Developments 109
11.5.5 SWOT Analysis 109
11.5.6 Key Strategies 109
11.6 ICON PLC 110
11.6.1 Company Overview 110
11.6.2 Financial Overview 110
11.6.3 Products/Services Offered 110
11.6.4 Key Developments 111
11.6.5 SWOT Analysis 111
11.6.6 Key Strategies 111
11.7 PRA Health Sciences (PRA) 112
11.7.1 Company Overview 112
11.7.2 Financial Overview 112
11.7.3 Products/Services Offered 112
11.7.4 Key Developments 113
11.7.5 SWOT Analysis 113
11.7.6 Key Strategies 113
11.8 Medpace 114
11.8.1 Company Overview 114
11.8.2 Financial Overview 114
11.8.3 Products/Services Offered 114
11.8.4 Key Developments 115
11.8.5 SWOT Analysis 115
11.8.6 Key Strategies 115
11.9 Laboratory Corporation of America Holdings 116
11.9.1 Company Overview 116
11.9.2 Financial Overview 116
11.9.3 Products/Services Offered 117
11.9.4 Key Developments 117
11.9.5 SWOT Analysis 117
11.9.6 Key Strategies 117
11.10 Pharmaceutical Product Development, LLC 118
11.10.1 Company Overview 118
11.10.2 Financial Overview 118
11.10.3 Products/Services Offered 118
11.10.4 Key Developments 118
11.10.5 SWOT Analysis 118
11.10.6 Key Strategies 119
11.11 WuXi AppTec 120
11.11.1 Company Overview 120
11.11.2 Financial Overview 120
11.11.3 Products/Services Offered 120
11.11.4 Key Developments 120
11.11.5 SWOT Analysis 121
11.11.6 Key Strategies 121
11.12 MD Biosciences 122
11.12.1 Company Overview 122
11.12.2 Financial Overview 122
11.12.3 Products/Services Offered 122
11.12.4 Key Developments 122
11.12.5 SWOT Analysis 122
11.12.6 Key Strategies 123
12 Appendix
12.1 References 124
12.2 Related Reports 124
13 List of Tables
TABLE 1 GLOBAL PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 29
TABLE 2 GLOBAL PRECLINICAL CRO MARKET, FOR TOXICOLOGY TESTING, BY REGION, 2022-2032 (USD MILLION) 31
TABLE 3 GLOBAL PRECLINICAL CRO MARKET, FOR BIOANALYSIS AND DRUG METABOLISM AND PHARMACOKINETICS (DMPK) STUDIES, BY REGION, 2022-2032 (USD MILLION) 32
TABLE 4 GLOBAL PRECLINICAL CRO MARKET, FOR OTHERS, BY REGION, 2022-2032 (USD MILLION) 33
TABLE 5 GLOBAL PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 34
TABLE 6 GLOBAL PRECLINICAL CRO MARKET, FOR ONCOLOGY, BY REGION, 2022-2032 (USD MILLION) 36
TABLE 7 GLOBAL PRECLINICAL CRO MARKET, FOR CENTRAL NERVOUS SYSTEM (CNS) DISORDERS, BY REGION, 2022-2032 (USD MILLION) 37
TABLE 8 GLOBAL PRECLINICAL CRO MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2022-2032 (USD MILLION) 38
TABLE 9 GLOBAL PRECLINICAL CRO MARKET, FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2022-2032 (USD MILLION) 39
TABLE 10 GLOBAL PRECLINICAL CRO MARKET, FOR RESPIRATORY DISEASES, BY REGION, 2022-2032 (USD MILLION) 40
TABLE 11 GLOBAL PRECLINICAL CRO MARKET, FOR INFECTIOUS DISEASES, BY REGION, 2022-2032 (USD MILLION) 41
TABLE 12 GLOBAL PRECLINICAL CRO MARKET, FOR DIABETES, BY REGION, 2022-2032 (USD MILLION) 42
TABLE 13 GLOBAL PRECLINICAL CRO MARKET, FOR OTHERS, BY REGION, 2022-2032 (USD MILLION) 43
TABLE 14 GLOBAL PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 44
TABLE 15 GLOBAL PRECLINICAL CRO MARKET, FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRIES, BY REGION, 2022-2032 (USD MILLION) 46
TABLE 16 GLOBAL PRECLINICAL CRO MARKET, FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022-2032 (USD MILLION) 47
TABLE 17 GLOBAL PRECLINICAL CRO MARKET, FOR ACADEMIC INSTITUTES, BY REGION, 2022-2032 (USD MILLION) 48
TABLE 18 GLOBAL PRECLINICAL CRO MARKET, BY REGION, 2022-2032 (USD MILLION) 49
TABLE 19 GLOBAL PRECLINICAL CRO MARKET SHARE, BY REGION, 2022 (%) 50
TABLE 20 GLOBAL PRECLINICAL CRO MARKET, BY REGION, 2022 & 2032 (USD MILLION) 50
TABLE 21 AMERICAS: PRECLINICAL CRO MARKET, BY REGION, 2022-2032 (USD MILLION) 51
TABLE 22 AMERICAS: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 52
TABLE 23 AMERICAS: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 52
TABLE 24 AMERICAS: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 53
TABLE 25 NORTH AMERICA: PRECLINICAL CRO MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 53
TABLE 26 NORTH AMERICA: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 54
TABLE 27 NORTH AMERICA: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 55
TABLE 28 NORTH AMERICA: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 55
TABLE 29 US: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 56
TABLE 30 US: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 56
TABLE 31 US: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 57
TABLE 32 CANADA: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 57
TABLE 33 CANADA: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 58
TABLE 34 CANADA: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 58
TABLE 35 LATIN AMERICA: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 59
TABLE 36 LATIN AMERICA: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 59
TABLE 37 LATIN AMERICA: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 60
TABLE 38 EUROPE: PRECLINICAL CRO MARKET, BY REGION, 2022-2032 (USD MILLION) 61
TABLE 39 EUROPE: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 62
TABLE 40 EUROPE: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 62
TABLE 41 EUROPE: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 63
TABLE 42 WESTERN EUROPE: PRECLINICAL CRO MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 63
TABLE 43 WESTERN EUROPE: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 64
TABLE 44 WESTERN EUROPE: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 65
TABLE 45 WESTERN EUROPE: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 65
TABLE 46 GERMANY: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 66
TABLE 47 GERMANY: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 66
TABLE 48 GERMANY: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 67
TABLE 49 FRANCE: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 67
TABLE 50 FRANCE: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 68
TABLE 51 FRANCE: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 68
TABLE 52 UK: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 69
TABLE 53 UK: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 69
TABLE 54 UK: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 70
TABLE 55 ITALY: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 70
TABLE 56 ITALY: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 71
TABLE 57 ITALY: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 71
TABLE 58 SPAIN: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 72
TABLE 59 SPAIN: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 72
TABLE 60 SPAIN: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 73
TABLE 61 REST OF WESTERN EUROPE: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 73
TABLE 62 REST OF WESTERN EUROPE: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 74
TABLE 63 REST OF WESTERN EUROPE: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 74
TABLE 64 EASTERN EUROPE: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 75
TABLE 65 EASTERN EUROPE: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 75
TABLE 66 EASTERN EUROPE: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 76
TABLE 67 ASIA-PACIFIC: PRECLINICAL CRO MARKET, BY COUNTRY, 2022-2032 (USD MILLION) 77
TABLE 68 ASIA-PACIFIC: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 78
TABLE 69 ASIA-PACIFIC: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 79
TABLE 70 ASIA-PACIFIC: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 79
TABLE 71 JAPAN: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 80
TABLE 72 JAPAN: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 80
TABLE 73 JAPAN: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 81
TABLE 74 CHINA: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 81
TABLE 75 CHINA: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 82
TABLE 76 CHINA: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 82
TABLE 77 INDIA: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 83
TABLE 78 INDIA: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 83
TABLE 79 INDIA: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 84
TABLE 80 AUSTRALIA: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 84
TABLE 81 AUSTRALIA: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 85
TABLE 82 AUSTRALIA: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 85
TABLE 83 SOUTH KOREA: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 86
TABLE 84 SOUTH KOREA: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 86
TABLE 85 SOUTH KOREA: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 87
TABLE 86 REST OF ASIA-PACIFIC: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 87
TABLE 87 REST OF ASIA-PACIFIC: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 88
TABLE 88 REST OF ASIA-PACIFIC: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 88
TABLE 89 MIDDLE EAST & AFRICA: PRECLINICAL CRO MARKET, BY REGION, 2022-2032 (USD MILLION) 89
TABLE 90 MIDDLE EAST & AFRICA: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 90
TABLE 91 MIDDLE EAST & AFRICA: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 90
TABLE 92 MIDDLE EAST & AFRICA: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 91
TABLE 93 MIDDLE EAST: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 91
TABLE 94 MIDDLE EAST: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 92
TABLE 95 MIDDLE EAST: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 92
TABLE 96 AFRICA: PRECLINICAL CRO MARKET, BY SERVICE, 2022-2032 (USD MILLION) 93
TABLE 97 AFRICA: PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022-2032 (USD MILLION) 93
TABLE 98 AFRICA: PRECLINICAL CRO MARKET, BY END USER, 2022-2032 (USD MILLION) 94
TABLE 99 KEY DEVELOPMENTS & STRATEGIES 96
14 List of Figures
FIGURE 1 MARKET SYNOPSIS 15
FIGURE 2 GLOBAL PRECLINICAL CRO MARKET: MARKET STRUCTURE 16
FIGURE 3 RESEARCH PROCESS OF MRFR 17
FIGURE 4 TOP-DOWN & BOTTOM-UP APPROACH 20
FIGURE 5 MARKET DYNAMICS: GLOBAL PRECLINICAL CRO MARKET 21
FIGURE 6 VALUE CHAIN: GLOBAL PRECLINICAL CRO MARKET 26
FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PRECLINICAL CRO MARKET 27
FIGURE 8 GLOBAL PRECLINICAL CRO MARKET SHARE, BY SERVICE, 2022 (%) 30
FIGURE 9 GLOBAL PRECLINICAL CRO MARKET, BY SERVICE, 2022 & 2032 (USD MILLION) 30
FIGURE 10 GLOBAL PRECLINICAL CRO MARKET SHARE, BY THERAPEUTIC AREA, 2022 (%) 35
FIGURE 11 GLOBAL PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2022 & 2032 (USD MILLION) 35
FIGURE 12 GLOBAL PRECLINICAL CRO MARKET SHARE, BY END USER, 2022 (%) 45
FIGURE 13 GLOBAL PRECLINICAL CRO MARKET, BY END USER, 2022 & 2032 (USD MILLION) 45
FIGURE 14 AMERICAS: PRECLINICAL CRO MARKET SHARE, BY REGION, 2022 (%) 51
FIGURE 15 NORTH AMERICA: PRECLINICAL CRO MARKET SHARE, BY COUNTRY, 2022 (%) 54
FIGURE 16 EUROPE: PRECLINICAL CRO MARKET SHARE, BY REGION, 2022 (%) 61
FIGURE 17 WESTERN EUROPE: PRECLINICAL CRO MARKET SHARE, BY COUNTRY, 2022 (%) 64
FIGURE 18 ASIA-PACIFIC: PRECLINICAL CRO MARKET SHARE, BY COUNTRY, 2022 (%) 78
FIGURE 19 MIDDLE EAST & AFRICA: PRECLINICAL CRO MARKET SHARE, BY REGION, 2022 (%) 89
FIGURE 20 GLOBAL PRECLINICAL CRO MARKET SHARE ANALYSIS 2022 (%) 95
